Timi risk score for stemi trial#

TIMI risk score accurately risk stratifies patients with undifferentiated chest pain presenting to an emergency department. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction.

Timi risk score for stemi trial#

TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Morrow DA, Antman EM, Charlesworth A et-al. female first-degree relative or mother younger than 65 yearsĪ percentage risk at 14 days of all-cause mortality, new or recurrent myocardial infarction, or severe recurrent ischemia requiring urgent revascularization.male first-degree relative or father younger than 55 years.family history of premature coronary artery disease.hypertension >140/90 mmHg or on anti-hypertensives.at least 3 risk factors for coronary artery disease, which include:.known coronary artery disease (CAD) (coronary stenosis ≥50%).ST changes of at least 0.5 mm in contiguous leads.at least 2 angina episodes in the last 24 hours.aspirin use within the last 7 days (patient has chest pain despite as required use in past 7 days).It is thought to have potential to improve the management of patients presenting to hospital with undifferentiated chest pain where ischemic heart disease is a potential diagnosis 3. The thrombolysis in myocardial infarction (TIMI) risk score is a prognostic risk stratification system that categorizes the risk of death and ischemic events in patients with unstable angina / non-ST elevation myocardial infarction and provides a basis for therapeutic decision making.